STACEY COPPERSMITH: Open Payments
NPI 1336537711 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$608 in 47 payments from 11 companies in 2025. Trend: 2023 $405 · 2024 $3,841 · 2025 $608
Food & beverage: $608
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| PFIZER INC. | 2 | $33 |
| Grifols USA, LLC | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 2 | $28 |
| Novo Nordisk Inc | 2 | $28 |
| Lilly USA, LLC | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: QULIPTA, VRAYLAR, CAPLYTA, NURTEC ODT, Prolastin-C Liquid, UBRELVY, ELIQUIS, CREON.
Industry payments across NE — which companies pay providers there.
